| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 227.46M | 250.22M | 290.41M | 354.05M | 350.26M | 202.91M |
| Gross Profit | 60.18M | 46.13M | 54.95M | 69.89M | 141.72M | 77.56M |
| EBITDA | 2.07M | -1.12M | -10.28M | -8.77M | 6.54M | 707.00K |
| Net Income | -1.52M | -4.90M | -20.84M | -17.41M | 2.38M | 8.15M |
Balance Sheet | ||||||
| Total Assets | 172.22M | 164.49M | 201.73M | 251.89M | 247.53M | 191.63M |
| Cash, Cash Equivalents and Short-Term Investments | 31.13M | 30.05M | 31.85M | 39.50M | 39.85M | 54.74M |
| Total Debt | 5.43M | 6.45M | 15.92M | 35.02M | 3.60M | 5.45M |
| Total Liabilities | 107.52M | 92.96M | 124.97M | 153.21M | 137.65M | 78.05M |
| Stockholders Equity | 64.70M | 71.53M | 76.77M | 98.68M | 109.88M | 113.58M |
Cash Flow | ||||||
| Free Cash Flow | 14.51M | 16.03M | 2.17M | -33.48M | -45.05M | 20.52M |
| Operating Cash Flow | 14.96M | 17.20M | 3.31M | -32.00M | -43.12M | 21.63M |
| Investing Cash Flow | -2.24M | -613.00K | 7.92M | 4.89M | -1.44M | 60.22M |
| Financing Cash Flow | -10.53M | -17.66M | -18.74M | 26.42M | -951.00K | -34.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £29.21B | 7.58 | 13.57% | 3.25% | 1.05% | -20.25% | |
70 Outperform | £7.38B | 11.60 | 5.08% | 4.02% | 0.82% | 160.81% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | £24.50M | -34.28 | 5.67% | ― | 0.03% | -5.67% | |
54 Neutral | £50.21M | -4.50 | -2.23% | ― | -15.87% | 90.20% | |
54 Neutral | £56.60M | -32.71 | -6.01% | ― | ― | ― | |
52 Neutral | £1.54B | 3.62 | 24.47% | ― | ― | ― |